Medicago prices overnight offering

Medicago (TSX:MDG) has carried out an overnight marketed offering and agreed to sell up to 34,117,600 units at a price of 51 cents a unit to raised $17.4 million. Each unit is comprised of one common share and one-quarter of a warrant, with each whole warrant exercisable to purchase another common share for 75 cents [...]

YM prices $40 million public offering

YM BioSciences (TSX:YM; AMEX:AMI) has priced a public offering of 25 million common shares at $1.60 a share to yield gross proceeds of $40 million for its drug development activities and general corporate purposes. The offering is expected to close on Dec. 17. The company also granted underwriters a 30-day option to purchase up to [...]

ConjuChem retains Bloom Burton

A committee of independent directors of insolvent ConjuChem Biotechnologies (TSX:CJB) has retained health care investment bankers Bloom Burton & Co. “to solicit and evaluate options for the company with a view to maximize value for shareholders and other stakeholders.” ConjuChem received court protection under the Companies’ Creditors Arrangement Act (Canada) on Feb. 26.  The TSX [...]